169 related articles for article (PubMed ID: 19152364)
1. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines.
Chittchang M; Batsomboon P; Ruchirawat S; Ploypradith P
ChemMedChem; 2009 Mar; 4(3):457-65. PubMed ID: 19152364
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D.
Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
4. Anticancer properties of lamellarins.
Bailly C
Mar Drugs; 2015 Feb; 13(3):1105-23. PubMed ID: 25706633
[TBL] [Abstract][Full Text] [Related]
5. Lamellarins as inhibitors of P-glycoprotein-mediated multidrug resistance in a human colon cancer cell line.
Plisson F; Huang XC; Zhang H; Khalil Z; Capon RJ
Chem Asian J; 2012 Jun; 7(7):1616-23. PubMed ID: 22473938
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.
Zheng L; Gao T; Ge Z; Ma Z; Xu J; Ding W; Shen L
Eur J Med Chem; 2021 Mar; 214():113226. PubMed ID: 33582387
[TBL] [Abstract][Full Text] [Related]
7. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.
Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of natural and unnatural lamellarins with saturated and unsaturated D-rings.
Ploypradith P; Petchmanee T; Sahakitpichan P; Litvinas ND; Ruchirawat S
J Org Chem; 2006 Dec; 71(25):9440-8. PubMed ID: 17137371
[TBL] [Abstract][Full Text] [Related]
9. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
10. A high-yielding modular access to the lamellarins: synthesis of lamellarin G trimethyl ether, lamellarin η and dihydrolamellarin η.
Imbri D; Tauber J; Opatz T
Chemistry; 2013 Nov; 19(45):15080-3. PubMed ID: 24123481
[No Abstract] [Full Text] [Related]
11. Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.
Neagoie C; Vedrenne E; Buron F; Mérour JY; Rosca S; Bourg S; Lozach O; Meijer L; Baldeyrou B; Lansiaux A; Routier S
Eur J Med Chem; 2012 Mar; 49():379-96. PubMed ID: 22305342
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs.
Liu ZZ; Wang Y; Tang YF; Chen SZ; Chen XG; Li HY
Bioorg Med Chem Lett; 2006 Mar; 16(5):1282-5. PubMed ID: 16338237
[TBL] [Abstract][Full Text] [Related]
13. Lamellarin D bioconjugates II: Synthesis and cellular internalization of dendrimer and nuclear location signal derivatives.
Pla D; Martí M; Farrera-Sinfreu J; Pulido D; Francesch A; Calvo P; Cuevas C; Royo M; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1112-21. PubMed ID: 19472996
[TBL] [Abstract][Full Text] [Related]
14. Design and total synthesis of Mannich derivatives of marine natural product lamellarin D as cytotoxic agents.
Shen L; Xie N; Yang B; Hu Y; Zhang Y
Eur J Med Chem; 2014 Oct; 85():807-17. PubMed ID: 25189362
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of lamellarin D analogues targeting topoisomerase I.
Ohta T; Fukuda T; Ishibashi F; Iwao M
J Org Chem; 2009 Nov; 74(21):8143-53. PubMed ID: 19791738
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis and evaluation of lamellarin alpha 20-Sulfate analogues.
Ridley CP; Reddy MV; Rocha G; Bushman FD; Faulkner DJ
Bioorg Med Chem; 2002 Oct; 10(10):3285-90. PubMed ID: 12150874
[TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships.
Marco E; Laine W; Tardy C; Lansiaux A; Iwao M; Ishibashi F; Bailly C; Gago F
J Med Chem; 2005 Jun; 48(11):3796-807. PubMed ID: 15916431
[TBL] [Abstract][Full Text] [Related]
19. Construction of Pentacyclic Lamellarin Skeleton via Grob Reaction: Application to Total Synthesis of Lamellarins H and D.
B Manjappa K; Lin JM; Yang DY
J Org Chem; 2017 Jul; 82(14):7648-7656. PubMed ID: 28665125
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.
Cananzi S; Merlini L; Artali R; Beretta GL; Zaffaroni N; Dallavalle S
Bioorg Med Chem; 2011 Aug; 19(16):4971-84. PubMed ID: 21783369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
